LON:DOCS Dr. Martens (DOCS) Share Price, News & Analysis → You didn’t listen then so you must now (From Porter & Company) (Ad) Free DOCS Stock Alerts GBX 87.40 +3.40 (+4.05%) (As of 05/31/2024 ET) Add Compare Share Share Today's Range 82.30▼ 87.7550-Day Range 67▼ 9752-Week Range 62▼ 162Volume3.45 million shsAverage Volume1.83 million shsMarket Capitalization£840.74 millionP/E Ratio874.00Dividend Yield6.86%Price TargetGBX 175 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades Get Dr. Martens alerts: Email Address Dr. Martens MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside100.2% UpsideGBX 175 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.18Based on 3 Articles This WeekInsider TradingAcquiring Shares£44,952 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.39 out of 5 stars 3.5 Analyst's Opinion Consensus RatingDr. Martens has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageDr. Martens has received no research coverage in the past 90 days.Read more about Dr. Martens' stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for DOCS. Previous Next 1.7 Dividend Strength Dividend LeadershipDr. Martens is a leading dividend payer. It pays a dividend yield of 6.78%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthDr. Martens does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Dr. Martens is 6,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about Dr. Martens' dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DOCS. Previous Next 2.3 News and Social Media Coverage News SentimentDr. Martens has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.31 average news sentiment score of Consumer Cyclical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Dr. Martens this week, compared to 2 articles on an average week.Search Interest34 people have searched for DOCS on MarketBeat in the last 30 days. This is an increase of 3,300% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Dr. Martens to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Dr. Martens insiders have bought more of their company's stock than they have sold. Specifically, they have bought £449.52 in company stock and sold GBX 0 in company stock.Percentage Held by InsidersOnly 2.77% of the stock of Dr. Martens is held by insiders.Percentage Held by Institutions71.54% of the stock of Dr. Martens is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Dr. Martens' insider trading history. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Dr. Martens is 874.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 138.36.Price to Earnings Ratio vs. SectorThe P/E ratio of Dr. Martens is 874.00, which means that it is trading at a more expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 378.73.Price to Earnings Growth RatioDr. Martens has a PEG Ratio of 0.04. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioDr. Martens has a P/B Ratio of 2.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… About Dr. Martens Stock (LON:DOCS)Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.Read More DOCS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOCS Stock News HeadlinesMay 15, 2024 | insidertrades.comDr. Martens plc (LON:DOCS) Insider Kenny Wilson Acquires 190 SharesMay 22, 2024 | reuters.comNetherlands' Martens to retire from internationalsMay 20, 2024 | finance.yahoo.comMarathon Partners urges Dr Martens to buy back stock, detail expense cutsMay 17, 2024 | yahoo.comDr. Martens Announces Shoe Collaboration With Streetwear Brand MadeMeMay 16, 2024 | msn.comDr Martens 'comfy' sandals that 'go with every summer outfit' have price slashed by €44 in mega saleMay 3, 2024 | mirror.co.ukNew Look's 'Dr Martens style' sandals that 'never rub' are a must-have for summerMay 2, 2024 | uk.news.yahoo.comNew Look's 'Dr Martens style' sandals that 'never rub' are a summer must-haveMay 1, 2024 | uk.finance.yahoo.comCould a takeover be on the cards for this ailing FTSE 250 legend?April 25, 2024 | msn.comNordstrom Rack is having a sale on the Dr. Martens platform for 75% offApril 18, 2024 | msn.comSave up to 75% on Dr. Martens at Nordstrom Rack’s Flash sale this week onlyApril 17, 2024 | msn.comGen Z favorite Dr. Martens is struggling as its CEO steps down—and it might be because their shoes last too longApril 17, 2024 | theguardian.comDr Martens investors should be kicking themselvesApril 16, 2024 | msn.comDr. Martens’ profit warning highlights U.S. consumer-confidence challengeApril 16, 2024 | finance.yahoo.comDr. Martens shares plunge to record low after weak US revenue outlookApril 16, 2024 | msn.comBootmaker Dr Martens names new CEO, flags tough year on weak demandApril 16, 2024 | msn.com'No blister' Dr Martens boots in six colours that are a 'lifelong love' just £80 in saleApril 16, 2024 | markets.businessinsider.comDr. Martens Sees Annual Result In Line With Guidance; Says 2025 Outlook ChallengingApril 16, 2024 | finance.yahoo.comDr. Martens Shares Tumble as Bootmaker Warns of Tough YearApril 16, 2024 | uk.finance.yahoo.comDr Martens shares dive to record low after profit warning and chief’s exitApril 16, 2024 | finance.yahoo.comDr. Martens Stock Plunges on Profit Warning, CEO ExitApril 14, 2024 | yahoo.comGwen Stefani Wears Sparkling Dr. Martens and Reunites With No Doubt at CoachellaApril 14, 2024 | finance.yahoo.comUnder The Bonnet, Dr. Martens' (LON:DOCS) Returns Look ImpressiveApril 10, 2024 | msn.comOlivia Rodrigo Casts Her Vote for 2024's It-SneakerApril 10, 2024 | msn.comThe Olivia Rodrigo Guide to Girl-Power MenswearApril 9, 2024 | msn.comHere’s Why More Shoe Brands Like Dr. Martens and New Balance Are Opting for Resale ProgramsSee More Headlines Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorConsumer Cyclical Industry Footwear & Accessories Sub-IndustryN/A Current SymbolLON:DOCS CUSIPN/A CIKN/A Webwww.drmartensplc.com Phone44 12 1415 7047FaxN/AEmployees2,591Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 175 High Stock Price TargetGBX 175 Low Stock Price TargetGBX 175 Potential Upside/Downside+100.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.10 Trailing P/E Ratio874.00 Forward P/E Ratio29.24 P/E Growth0.04Net Income£103.20 million Net Margins10.56% Pretax MarginN/A Return on Equity29.07% Return on Assets10.31% Debt Debt-to-Equity Ratio143.48 Current Ratio2.44 Quick Ratio1.13 Sales & Book Value Annual Sales£977.50 million Price / Sales0.86 Cash FlowGBX 6.12 per share Price / Cash Flow14.29 Book ValueGBX 37 per share Price / Book2.36Miscellaneous Outstanding Shares961,940,000Free FloatN/AMarket Cap£840.74 million OptionableNot Optionable Beta0.01 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Kenneth Wilson (Age 58)CEO & Director Comp: $773kMr. Onyeije Ogueri Nwokorie (Age 54)Chief Brand Officer Comp: $67kMr. Geert Peeters (Age 58)Chief Operating Officer Mr. Ronald GarricksChief Information OfficerMs. Meg JohnsonChief Marketing OfficerMs. Emily Clare Reichwald (Age 49)Chief People & Sustainability Officer and Company Secretary Mr. Sean O'NeillChief Digital OfficerMr. Derek ChanPresident of APACMr. Adam M. MeekChief Product OfficerMs. Jennifer SomerPresident of AmericasMore ExecutivesKey CompetitorsMulberry GroupLON:MULPittardsLON:PTDRPC GroupLON:RPCBellwayLON:BWYGames Workshop GroupLON:GAWView All CompetitorsInsidersKenny WilsonBought 190 shares on 5/13/2024Total: £15,010.00 ($79.00/share)Jon MortimoreBought 159 shares on 4/11/2024Total: £14,946.00 ($94.00/share)Kenny WilsonBought 163 shares on 3/11/2024Total: £14,996.00 ($92.00/share)Kenny WilsonBought 172 shares on 2/12/2024Total: £14,964.00 ($87.00/share)Jon MortimoreBought 185 shares on 1/11/2024Total: £14,985.00 ($81.00/share)View All Insider Transactions DOCS Stock Analysis - Frequently Asked Questions Should I buy or sell Dr. Martens stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" DOCS shares. View DOCS analyst ratings or view top-rated stocks. What is Dr. Martens' stock price target for 2024? 1 Wall Street analysts have issued 12 month target prices for Dr. Martens' stock. Their DOCS share price targets range from GBX 175 to GBX 175. On average, they anticipate the company's share price to reach GBX 175 in the next year. This suggests a possible upside of 100.2% from the stock's current price. View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts. How have DOCS shares performed in 2024? Dr. Martens' stock was trading at GBX 88.60 at the beginning of the year. Since then, DOCS shares have decreased by 1.4% and is now trading at GBX 87.40. View the best growth stocks for 2024 here. How often does Dr. Martens pay dividends? What is the dividend yield for Dr. Martens? Dr. Martens declared a dividend on Thursday, May 30th. Stockholders of record on Thursday, August 29th will be given a dividend of GBX 0.99 per share on Tuesday, October 1st. This represents a dividend yield of 1.18%. The ex-dividend date of this dividend is Thursday, August 29th. The official announcement can be viewed at this link. Read our dividend analysis for DOCS. Is Dr. Martens a good dividend stock? Dr. Martens (LON:DOCS) pays an annual dividend of GBX 6 per share and currently has a dividend yield of 6.78%. DOCS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 6,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for DOCS. How do I buy shares of Dr. Martens? Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:DOCS) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersDems have chosen Biden replacement?Paradigm PressDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media ‘America’s Top Trader’ Who Predicted the Biggest Financial Events of The Last 30 Years, Issues New WARNING:InvestorPlaceNYSE biotech company's drug could be as revolutionary as penicillin!Financial Markets Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.